Citius Pharmaceuticals is trading 5.2% up at $0.61, with the move most consistent with broader risk-on sentiment as the Nasdaq Composite rises 1.10% and the S&P 500 gains 0.45%.
- No fresh company-specific announcement was identified for August 27, 2026.
- Fiscal third-quarter results and a Nasdaq compliance extension predate the session and do not clearly explain today’s gain.